BioSig Technologies Enters Material Definitive Agreement
Ticker: STEX · Form: 8-K · Filed: Mar 12, 2024 · CIK: 1530766
| Field | Detail |
|---|---|
| Company | Biosig Technologies, Inc. (STEX) |
| Form Type | 8-K |
| Filed Date | Mar 12, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001, $500,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, filing
TL;DR
BioSig just signed a big deal, filing an 8-K on it.
AI Summary
On March 7, 2024, BioSig Technologies, Inc. entered into a material definitive agreement, the specifics of which are detailed in this Form 8-K filing. The company, incorporated in Delaware with its principal executive offices in Westport, Connecticut, is involved in the electromedical and electrotherapeutic apparatus industry.
Why It Matters
This filing indicates a significant new agreement for BioSig Technologies, which could impact its future operations, partnerships, and financial performance.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce new risks or opportunities, and the lack of specific details in this initial filing warrants a medium risk assessment.
Key Numbers
- 001-38659 — SEC File Number (Identifies the company's filing history with the SEC.)
- 264333375 — IRS Number (Company's Employer Identification Number.)
Key Players & Entities
- BioSig Technologies, Inc. (company) — Registrant
- March 7, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Westport, Connecticut (location) — Address of principal executive offices
- 3845 (industry_code) — Standard Industrial Classification
FAQ
What is the nature of the material definitive agreement entered into by BioSig Technologies, Inc. on March 7, 2024?
The filing states that an "Entry into a Material Definitive Agreement" is the item information, but the specific details of the agreement are not provided in this excerpt.
What is BioSig Technologies, Inc.'s Standard Industrial Classification code?
BioSig Technologies, Inc.'s Standard Industrial Classification code is 3845, which corresponds to ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS.
Where are BioSig Technologies, Inc.'s principal executive offices located?
The principal executive offices of BioSig Technologies, Inc. are located at 55 Greens Farms Road, 1st Floor, Westport, Connecticut, 06880.
What is the date of the earliest event reported in this Form 8-K filing?
The date of the earliest event reported in this Form 8-K filing is March 7, 2024.
What is the company's state of incorporation?
BioSig Technologies, Inc. is incorporated in Delaware.
Filing Stats: 526 words · 2 min read · ~2 pages · Grade level 11.7 · Accepted 2024-03-12 09:38:57
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share BSGM The NASDAQ Capital M
- $500,000 — ry Note (the "Note") to an investor for $500,000. The Company designated its 12% Notes d
Filing Documents
- form8-k.htm (8-K) — 39KB
- ex4-1.htm (EX-4.1) — 126KB
- 0001493152-24-009635.txt ( ) — 356KB
- bsgm-20240307.xsd (EX-101.SCH) — 3KB
- bsgm-20240307_lab.xml (EX-101.LAB) — 33KB
- bsgm-20240307_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BIOSIG TECHNOLOGIES, INC. Date: March 12, 2024 By: /s/ Frederick D. Hrkac Name: Frederick D. Hrkac Title: Principal Executive Officer